Sfoglia per Titolo
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients
2012-01-01 M., Scartozzi; C., Loretelli; R., Berardi; C., Pierantoni; R. R., Silva; D., Mari; R., Giampieri; L., Faloppi; M., Pistelli; E., Maccaroni; A., Bittoni; M. D., Prete; E., Galizia; Cascinu, Stefano
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
2010-01-01 Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, A.
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
2019-01-01 Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
2017-01-01 Laquente, B.; Lopez-Martin, J.; Richards, D.; Illerhaus, G.; Chang, D. Z.; Kim, G.; Stella, P.; Richel, D.; Szcylik, C.; Cascinu, S.; Frassineti, G. L.; Ciuleanu, T.; Hurt, K.; Hynes, S.; Lin, J.; Lin, A. B.; Hoff, D.; Calvo, E.
A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
2007-01-01 Geulibter, A. J.; Gamucci, T.; Pollera, C. F.; Di Costanzo, F.; Nuzzo, C.; Gabriele, A.; Signorelli, C.; Gasperoni, S.; Ferraresi, V.; Giannarelli, D.; Cognetti, F.; Zeuli, M.
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
2016-01-01 Belli, Carmen; Piemonti, Lorenzo; D'Incalci, Maurizio; Zucchetti, Massimo; Porcu, Luca; Cappio, Stefano; Doglioni, Claudio; Allavena, Paola; Ceraulo, Domenica; Maggiora, Paola; Dugnani, Erica; Cangi Maria, Giulia; Garassini, Greta; Reni, Michele
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27)
2010-01-01 Govi, S; Dolcetti, R; Ponzoni, M; Pasini, E; Doglioni, C; Bertoni, F; Cabrera, Me; Stelitano, C; Zaja, F; Sanz, Cm; Cavalli, F; Zucca, E; Ferreri, A
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis
2011-01-01 Comi, G; Cohen, Ja; Arnold, Dl; Wynn, D; Filippi, M; FORTE Study, Group
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
2022-01-01 Pantzaris, Marios C; Bakirtzis, Christos; Grigoriadis, Nikolaos; Hadjigeorgiou, Georgios; Dardiotis, Efthimos; Loucaides, George; Ntzani, Evangelia; Markozannes, Georgios; Omorfos, Savvas; Valsasina, Paola; Messina, Roberta; Preziosa, Paolo; Rocca, Maria A; Patrikios, Ioannis
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
2006-01-01 Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
2006-01-01 Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V
Phase response effet of lormetazepam in the treatment of depressive insomnia.
2004-01-01 Pontiggia, A; Benedetti, F; Bernasconi, A; Colombo, CRISTINA ANNA; Florita, M; Dallaspezia, S.
Phase-response effects of lormetazepam in depressive insomnia
2003-01-01 Pontiggia, A; Benedetti, F; Smeraldi, E; Bernasconi, A; Florita, M; Colombo, CRISTINA ANNA; Cropanese, I.
Phatophysiology and treatment of ftigue in multiple sclerosis
2002-01-01 Comi, Giancarlo; Colombo, B; Rossi, P.
Phenomenal effects of microelements’ numerosity on texture appearance
2014-01-01 Giora, Enrico
Phenomenological Distinctions Between Empathy De Vivo and Empathy in Fiction: From Contemporary Direct Perception Theory Back to Edith Stein’s Eidetics of Empathy
2019-01-01 DE VECCHI, FRANCESCA MARIA; Forle', Francesca
The Phenomenological revolution
2007-01-01 De Monticelli, Roberta
Phenomenologizing cognitive Neuroscience?
2011-01-01 DE MONTICELLI, Roberta; DE VECCHI, FRANCESCA MARIA
Phenomenology and Analytic Philosophy: Perspectives on Mind and Consciousness
2011-01-01 DE MONTICELLI, Roberta; DE VECCHI, FRANCESCA MARIA
Phenomenology in Italy
2020-01-01 Costa, Vincenzo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients | 1-gen-2012 | M., Scartozzi; C., Loretelli; R., Berardi; C., Pierantoni; R. R., Silva; D., Mari; R., Giampieri; L., Faloppi; M., Pistelli; E., Maccaroni; A., Bittoni; M. D., Prete; E., Galizia; Cascinu, Stefano | |
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma | 1-gen-2010 | Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, A. | |
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients | 1-gen-2019 | Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C. | |
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients | 1-gen-2017 | Laquente, B.; Lopez-Martin, J.; Richards, D.; Illerhaus, G.; Chang, D. Z.; Kim, G.; Stella, P.; Richel, D.; Szcylik, C.; Cascinu, S.; Frassineti, G. L.; Ciuleanu, T.; Hurt, K.; Hynes, S.; Lin, J.; Lin, A. B.; Hoff, D.; Calvo, E. | |
A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer | 1-gen-2007 | Geulibter, A. J.; Gamucci, T.; Pollera, C. F.; Di Costanzo, F.; Nuzzo, C.; Gabriele, A.; Signorelli, C.; Gasperoni, S.; Ferraresi, V.; Giannarelli, D.; Cognetti, F.; Zeuli, M. | |
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma | 1-gen-2016 | Belli, Carmen; Piemonti, Lorenzo; D'Incalci, Maurizio; Zucchetti, Massimo; Porcu, Luca; Cappio, Stefano; Doglioni, Claudio; Allavena, Paola; Ceraulo, Domenica; Maggiora, Paola; Dugnani, Erica; Cangi Maria, Giulia; Garassini, Greta; Reni, Michele | |
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) | 1-gen-2010 | Govi, S; Dolcetti, R; Ponzoni, M; Pasini, E; Doglioni, C; Bertoni, F; Cabrera, Me; Stelitano, C; Zaja, F; Sanz, Cm; Cavalli, F; Zucca, E; Ferreri, A | |
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis | 1-gen-2011 | Comi, G; Cohen, Ja; Arnold, Dl; Wynn, D; Filippi, M; FORTE Study, Group | |
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study | 1-gen-2022 | Pantzaris, Marios C; Bakirtzis, Christos; Grigoriadis, Nikolaos; Hadjigeorgiou, Georgios; Dardiotis, Efthimos; Loucaides, George; Ntzani, Evangelia; Markozannes, Georgios; Omorfos, Savvas; Valsasina, Paola; Messina, Roberta; Preziosa, Paolo; Rocca, Maria A; Patrikios, Ioannis | |
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma | 1-gen-2006 | Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V | |
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma | 1-gen-2006 | Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V | |
Phase response effet of lormetazepam in the treatment of depressive insomnia. | 1-gen-2004 | Pontiggia, A; Benedetti, F; Bernasconi, A; Colombo, CRISTINA ANNA; Florita, M; Dallaspezia, S. | |
Phase-response effects of lormetazepam in depressive insomnia | 1-gen-2003 | Pontiggia, A; Benedetti, F; Smeraldi, E; Bernasconi, A; Florita, M; Colombo, CRISTINA ANNA; Cropanese, I. | |
Phatophysiology and treatment of ftigue in multiple sclerosis | 1-gen-2002 | Comi, Giancarlo; Colombo, B; Rossi, P. | |
Phenomenal effects of microelements’ numerosity on texture appearance | 1-gen-2014 | Giora, Enrico | |
Phenomenological Distinctions Between Empathy De Vivo and Empathy in Fiction: From Contemporary Direct Perception Theory Back to Edith Stein’s Eidetics of Empathy | 1-gen-2019 | DE VECCHI, FRANCESCA MARIA; Forle', Francesca | |
The Phenomenological revolution | 1-gen-2007 | De Monticelli, Roberta | |
Phenomenologizing cognitive Neuroscience? | 1-gen-2011 | DE MONTICELLI, Roberta; DE VECCHI, FRANCESCA MARIA | |
Phenomenology and Analytic Philosophy: Perspectives on Mind and Consciousness | 1-gen-2011 | DE MONTICELLI, Roberta; DE VECCHI, FRANCESCA MARIA | |
Phenomenology in Italy | 1-gen-2020 | Costa, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile